Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
This study is ongoing, but not recruiting participants.
Study NCT00489515 Information provided by National Cancer Institute (NCI)
First Received: June 20, 2007 Last Updated: September 18, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Colorectal Cancer
Gallbladder Cancer
Gastric Cancer
Pancreatic Cancer
Small Intestine Cancer
Additional conditions recognized in this trial
Colorectal Neoplasms
Duodenal Neoplasms
Gallbladder Neoplasms
Ileal Neoplasms
Intestinal Neoplasms
Jejunal Neoplasms
Pancreatic Neoplasms
Stomach Neoplasms
More general conditions related to this trial
Biliary Tract Diseases
Biliary Tract Neoplasms
Colonic Diseases
Digestive System Diseases
Digestive System Neoplasms
Duodenal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Gallbladder Diseases
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Ileal Diseases
Intestinal Diseases
Jejunal Diseases
Neoplasms
Neoplasms by Site
Pancreatic Diseases
Rectal Diseases
Stomach Diseases
Interventions listed in this trial
isosulfan blue
laboratory biomarker analysis
conventional surgery
lymphadenectomy
lymphangiography
sentinel lymph node biopsy
Sponsors listed in this trial
Wake Forest University
National Cancer Institute (NCI)
Back to top of Main Content
